模块化设计
癌症免疫疗法
免疫疗法
免疫系统
癌症疫苗
癌症
接种疫苗
免疫原性
卵清蛋白
抗原
dna疫苗
信使核糖核酸
癌症研究
疫苗效力
计算生物学
获得性免疫系统
转染
抗原呈递
免疫学
基因传递
抗原处理
生物
医学
计算机科学
作者
Keyang Li,Danhua Zhou,Fei Li,Zhen Li,Shaobin Wu,Yanhui Li,Shasha He,Huayu Tian
标识
DOI:10.1002/adfm.202511463
摘要
Abstract Messenger RNA (mRNA) vaccines revolutionize cancer immunotherapy, offering powerful tools to elicit precise, antigen‐specific immune responses. However, the limited efficiency of current mRNA delivery systems and the lack of real‐time immune monitoring tools hinder their full therapeutic potential. In this study, a modular platform that integrates a self‐adjuvanting mRNA delivery system with a self‐targeting vaccine efficacy reporter (VER), allowing for optimized therapeutic regulation in real‐time is developed. This platform utilizes peptide‐lipid nanoparticle (PLNP) incorporating cathepsin B‐activatable melittin lipidoid to deliver mRNA encoding ovalbumin (mOVA), which triggers robust immune activation through the STING pathway, significantly enhancing both transfection efficiency and vaccine potency. The VER probe features a leucine‐caged near‐infrared fluorescent moiety designed to detect antigen presentation by exploiting endoplasmic reticulum aminopeptidase 1 (ERAP1), a key enzyme upregulated during antigen processing. Following vaccination with PLNP/mOVA, ERAP1 activation leads to fluorescence emission by VER, enabling real‐time, non‐invasive tracking of immune activation. Through this modular integration, the system provides both self‐adjuvanting mRNA delivery and precise immune activation reporting. This approach supports the timely optimization of therapeutic strategies in cancer immunotherapy, offering the potential for more effective and personalized vaccination and treatment regimens.
科研通智能强力驱动
Strongly Powered by AbleSci AI